We welcome the interest shown by Meyer et al in our article on propofol as an induction agent for neonatal endotracheal intubation. However, the authors seem to have made a few misinterpretations of our trial results. We did not report an increase in blood pressure, as claimed by these authors. In our propofol group, the median mean blood pressures were 42, 42.5, and 41 mmHg at baseline and during and after intubation, respectively, as illustrated in the original article. We also showed that the median mean blood pressure was comparable between the 2 study groups. We did not encounter any major complication in our trial, although it was not powered to detect adverse effects.

Gottschling et al have performed a number of studies using propofol as a sedation agent for diagnostic and therapeutic procedures in children outside the intensive care or anesthetic settings. In their studies, avoidance of intubation...

You do not currently have access to this content.